A5064682115- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- Heart Rate Variability and Autonomic Control
- Cardiac Imaging and Diagnostics
- Cardiac Valve Diseases and Treatments
- Coronary Artery Anomalies
- Cardiovascular and Diving-Related Complications
- Cardiovascular Function and Risk Factors
- Cardiac Structural Anomalies and Repair
- ECG Monitoring and Analysis
- Cardiovascular Disease and Adiposity
- Cardiac tumors and thrombi
- Cerebrovascular and Carotid Artery Diseases
- Congenital Heart Disease Studies
- Cardiovascular Syncope and Autonomic Disorders
- Coronary Interventions and Diagnostics
- Cardiomyopathy and Myosin Studies
- Infective Endocarditis Diagnosis and Management
- Blood Pressure and Hypertension Studies
- Vascular anomalies and interventions
- Kawasaki Disease and Coronary Complications
- Aortic Disease and Treatment Approaches
- Renal and Vascular Pathologies
Memorial Ankara Hospital
2016-2025
Hacettepe University
2010-2021
Keio University
2019
Bağcılar Eğitim ve Araştırma Hastanesi
2015
Hacettepe University Hospital
1997-2015
Institute of Cardiology
2012
APT Therapeutics (United States)
2012
Turkish Society of Cardiology
2012
Advisory Board Company (United States)
2012
Novem (Netherlands)
2011
à Use of Class III is discouraged by the ESC. Levels EvidenceLevel Evidence A Data derived from multiple randomized clinical trials or meta-analyses Level B a single trial large nonrandomized studies C Consensus opinion experts and/or small studies; retrospective and registriesFigure 1 Clinical classification mode heart failure (Forrester classification).H I-IV refers to haemodynamic severity, with reference figures for CI pulmonary capillary pressures shown on vertical horizontal axes,...
The Task Force has classified and ranked the usefulness or efficacy of recommended procedure and/or treatments Level Evidence as indicated in tables below: Classes RecommendationsClass I general agreement that a given diagnostic procedure/treatment is beneficial, useful effective; Class II Conflicting evidence divergence opinion about usefulness/efficacy treatment; IIa Weight evidence/opinion favour usefulness/efficacy; IIb Usefulness/efficacy less well established by evidence/opinion; III...
The effect of intensified platelet inhibition for patients with unstable angina or myocardial infarction without ST-segment elevation who do not undergo revascularization has been delineated.In this double-blind, randomized trial, in a primary analysis involving 7243 under the age 75 years receiving aspirin, we evaluated up to 30 months treatment prasugrel (10 mg daily) versus clopidogrel (75 daily). In secondary 2083 older, 5 clopidogrel.At median follow-up 17 months, end point death from...
Guidelines and Expert Consensus documents aim to present all the relevant evidence on a particular issue in order help physicians weigh benefits risks of diagnostic or therapeutic procedure.They should be helpful everyday clinical decisionmaking.A great number Documents have been issued recent years by European Society Cardiology (ESC) different organisations other related societies.This profusion can put at stake authority validity guidelines, which only guaranteed if they developed an...
The prolongation of intraatrial and interatrial conduction time the inhomogeneous propagation sinus impulses have been shown in patients with atrial fibrillation. Recently P wave dispersion (PWD), which is believed to reflect conduction, has proposed as being useful for prediction paroxysmal fibrillation (PAF). Ninety consecutive (46 men, 44 women; aged 55 +/- 13 years) a history idiopathic PAF 70 healthy subjects (42 28 mean age 53 14 were studied. duration was calculated all 12 leads...
The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient, where necessary patient's guardian or carer.It is also professional's verify rules regulations...
Previous studies evidenced that increased monocyte count or activity and lower high-density lipoprotein (HDL) cholesterol levels were associated with more prevalent atrial fibrillation (AF) which attributed to pro-inflammatory pro-oxidant effects. Monocyte-to-HDL ratio (M/H ratio) is a recently emerged indicator of inflammation oxidative stress have been only studied in patients chronic kidney disease. We aimed investigate the prognostic impact M/H on AF recurrence after cryoballoon-based...
Objectives To provide an accurate, web-based tool for stratifying patients with atrial fibrillation to facilitate decisions on the potential benefits/risks of anticoagulation, based mortality, stroke and bleeding risks. Design The new was developed, using stepwise regression, all then applied lower risk patients. C-statistics were compared CHA 2 DS -VASc 30-fold cross-validation control overfitting. External validation undertaken in independent dataset, Outcome Registry Better Informed...
There are major challenges ahead for clinicians treating patients with atrial fibrillation (AF). The population AF is expected to expand considerably and yet, apart from anticoagulation, therapies used in have not been shown consistently impact on mortality or reduce adverse cardiovascular events. New approaches management, including the use of novel technologies structured, integrated care, potential enhance clinical phenotyping result better treatment selection stratified therapy. Here, we...
Among patients with atrial fibrillation (AF), women are at higher risk of stroke than men. Using prospective cohort data from a large global population nonvalvular AF, we sought to identify any differences in the use anticoagulants for prevention and men.This was multicenter observational registry 858 randomly selected sites 30 countries. A total 17 184 newly diagnosed (≤6 weeks) AF ≥1 additional investigator-defined factor(s) were recruited (March 2010 June 2013). The main outcome measure...
P-wave dispersion is defined as the difference between maximum and minimum duration recorded from multiple different-surface ECG leads. It has been known that increased reflect prolongation of intraatrial interatrial conduction time inhomogeneous propagation sinus impulses, which are well-known electrophysiologic characteristics in patients with atrial arrhythmias especially paroxysmal fibrillation. Extensive clinical evaluation performed assessment risk for fibrillation without apparent...
BackgroundAsymptomatic atrial fibrillation is often detected incidentally. Prognosis and optimal therapy for asymptomatic compared with symptomatic uncertain. This study compares clinical characteristics, treatment, 2-year outcomes of presentations.MethodsGlobal Anticoagulant Registry in the Field-Atrial Fibrillation (GARFIELD-AF) a global, prospective, observational newly diagnosed ≥1 stroke risk factors (http://www.clinicaltrials.gov, unique identifier: NCT01090362). Patients were...